An mRNA vaccine, a cousin to the COVID vaccines that blunted the pandemic, has entered human trials as a treatment for lung ...

金融界10月25日消息，申联生物披露投资者关系活动记录表显示，公司的mRNA技术在兽用生物制品领域对动物传染病的防治具有巨大潜力，优点包括更易于多联多价疫苗的开发，研发时间短，量产高，生物安全风险低，可更有效诱导细胞免疫和体液免疫等。公司积极推进mRNA技术在宠物疫苗、治疗药品以及未被完全满足的临床需求的重大动 ...

Katalin Karikó, a Nobel Prize laureate, Penn professor, and renowned mRNA researcher from Abington, has been inducted into ...

According to an infectious disease expert, Hong Kong’s flu season is expected to start in December; it is likely to have two ...

Prenatal gene therapy via mRNA LNPs fixes faulty genes in fetal brain cells in animal model of neurodevelopmental syndrome.

New research underscores the role of the immune system in depression, linking inflammation to poor response to standard ...

Updated COVID-19 vaccines targeting JN.1-lineage omicron variants of the coronavirus are now available in the U.S. for the ...

Moderna shares rebound after six days of losses. Analysts mixed on stock with Strong Sell rating but potential for future growth.

Anyone who got sick with COVID-19 during the summer wave in South Florida has some protection against a future infection, but ...

Montréal and UK-based startup Epitopea has raised $31 million USD ($43 million CAD) in what it called pre-Series A funding ...

The science behind vaccines is based on the fundamental principle of training the immune system to recognize and fight ...

We expect BioNTech SE BNTX to surpass expectations when it reports third-quarter 2024 results on Nov. 4, before the opening ...